Pureos Bioventures has backed five spinouts so far from its multi-corporate-backed, biotech-focused fund.

Pureos Bioventures has backed five spinouts so far from its inaugural biotech-focused fund, which has reached its final close.

HBM Healthcare chipped in additional funding to bring University of Basel spinout Polyneuron's series A round to $39.7m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Novartis-backed Inflazome, which advances University of Queensland and Trinity College Dublin research to develop treatments for inflammation, has been bought by Roche for $448m.

Inflazome, which advances University of Queensland and Trinity College Dublin research to develop treatments for inflammation, has been bought by Roche for $448m.

Compass Pathways has raised more than $127m in an upsized initial public offering that provided an exit to Otsuka Pharmaceuticals.

Legal & General is among the limited partners for Kindred Capital’s second fund, which also attracted University of Chicago and will invest in early-stage European startups.

University of Chicago is among the limited partners for Kindred Capital’s second fund, which will invest in early-stage European startups.